Live from ClinicalTrials.gov + Open Targets, fetched 2026-11-12 02:15 UTC. Every row links to its source record.
Postmortem · what the sponsor and named sources said, kept apart from what merely happened at the same time
Safety Study of Sildenafil in Treatment of Cerebral Aneurysm Vasospasm
NCT00871065 · University of Nebraska · PHASE2 · withdrawn · last registry update 2023-08-15 · Decision brief
No research has been run for this trial yet, so only the registry's own reason and the timeline are shown.
What was said, and by whom
Stated is the sponsor's own words; Reported is a named third party. The category is our label from a fixed list; the quote is the evidence.
| Kind | Quote | Our category | Source |
|---|---|---|---|
| Stated | “PI decision” | – | Registry record, University of Nebraska |
Also happening at the time. Not shown to be a cause.
Registry events on other trials of drugs against PDE5A within 12 months either side of this trial's last update, live from ClinicalTrials.gov. Nothing here was stated as a reason.
- 2024-08-02Results posted on the registry: Shionogi, MT-1186 + Rosuvastatin (NCT04481789)
- 2024-07-26Phase 3 first posted: University of Alabama at Birmingham, Sildenafil 50 mg Oral Tablet + Placebo Oral Tablet (NCT06522854)
- 2024-07-25Phase 3 first posted: University Medical Centre Ljubljana, Tadalafil 5mg (NCT06520839)
- 2024-07-10Results posted on the registry: Montefiore Medical Center, Sildenafil + Placebo Oral Tablet (NCT03199612)
- 2024-07-08Phase 3 first posted: Tanta University, Vardenafil 5 Mg Oral Tablet (NCT06491108)
- 2024-06-20Phase 3 first posted: Al-Azhar University, Tadalafil (NCT06466369)
- 2024-05-20Phase 3 first posted: Ain Shams University, Dapagliflozin 10mg Tab + Pentoxifylline 400 MG (NCT06421870)
- 2024-05-20Phase 3 first posted: Tanta University, Pentoxifylline + Probiotic Formula (NCT06422000)
- 2024-05-16Also stopped (withdrawn): University of British Columbia, Sildenafil (NCT04122105)
- 2024-04-22Phase 3 first posted: University of Alabama at Birmingham, Sildenafil 50 mg Oral Tablet + Placebo Oral Tablet (NCT06377098)
- 2024-02-28Also stopped (terminated): Uniformed Services University of the Health Sciences, Sildenafil Citrate 50Mg Tab + Gadolinium contrast infusion (NCT04058132)
- 2024-02-20Also stopped (terminated): Nanjing First Hospital, Nanjing Medical University, Sildenafil (NCT02284737)
- 2024-01-11Also stopped (terminated): Baylor College of Medicine, Pentoxifylline (NCT01774487)
- 2023-11-13Results posted on the registry: Actelion, FDC macitentan/tadalafil + Macitentan 10 mg (NCT03904693)
- 2023-11-08Phase 3 first posted: University Hospital, Rouen, Sildenafil (NCT06123156)
- 2023-11-07Also stopped (terminated): Clear Creek Bio, Inc., Brequinar Sodium + Dipyridamole 75 MG (NCT05166876)
- 2023-10-31Results posted on the registry: University of Mississippi Medical Center, Sildenafil 100 mg + Bosentan 125 mg (NCT04770155)
- 2023-10-31Also stopped (terminated): University of Mississippi Medical Center, Sildenafil 100 mg + Bosentan 125 mg (NCT04770155)
- 2023-10-12Results posted on the registry: Baylor College of Medicine, Pentoxifylline (NCT01774487)
- 2023-10-04Also stopped (terminated): Legacy Health System, Trental Pill (NCT03916068)
- 2023-09-26Phase 3 first posted: Sunnybrook Health Sciences Centre, modified PENTOCLO (mPENTOCLO) + sham mPENTOCLO (NCT06055257)
- 2023-09-21Results posted on the registry: Futura Medical Developments Ltd., Tadalafil 5mg (Male) + Tadalafil 5mg (Female) (NCT04984993)
- 2023-09-15Phase 3 first posted: University of Brasilia, Miltefosine 50mg + Pentoxifylline 400mg (NCT06040489)
- 2023-09-14Results posted on the registry: University of Cincinnati, Trental (NCT01508221)
- 2023-08-02Phase 3 first posted: Beni-Suef University, tadalafil + Sildenafil (NCT05971667)
What is not public
- Internal portfolio and board discussions
- Unpublished trial data and interim analyses
- Terms of any partner or licence decision